杨宁介入医学网

肝炎肝硬化和肝细胞肝癌，一个病人两种病； Tumor Burden Liver Function Performance Status 三要素评估 https://www.hepatitisc.uw.edu/ BCLC 对A期的治疗策略已经发生变化...

HepaSphere玻璃小瓶直立，把盖打开，注意保留金属部分 反复旋转HepaSphere玻璃小瓶使微粒散开 20-30ml注射器，20G针头，加0.9%盐水20ml，稀释50mg阿霉素。 新20ml注射器和20G针头，抽吸回10m l阿霉素到注射器 20ml注射器，用新的20G针头，注射全部10ml阿霉素...

Conclusions Administration of RE is safe Cohesive multidisciplinary working is critical There is a strong evidence base for the efficacy of RE in delaying TTP and improving median survival in first, second and subsequent lines of therapy f...

Setting up your own Multidisciplinary Team for RE Treatment at your institution Radiation/medical oncologist Nuclear medicine physician Radiopharmacy Interventional radiologistand support staff Radiation protection Mentorship programme Col...

SIR-Spherescan down-size inoperable disease to either resection or ablation Investigator n Tx line #Outcomes Tumour Type(s) Whitney 44 SIR-Spheres 2nd4th 4 R0 CRC; OeC Hoffmann 46 SIR-Spheres salvage 5 RF 3 BrC; CRC; PaC Gray 36 SIR-Spheres...

Disease status post-FOLFIRI+cetuximab Borderline volume post-chemo left lobe FOLFOX Chemo + RE Sharma RA et al. J Clin Oncol25: 1099-1106, 2007 Static Bremsstrahlung post-RE SPECT-CT Post-RE CT scan pre-and 3 months post-RE Pre-RE Post-RE...

Sato et al. Radiology 2008;247:507-515 Sato KT1, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, Nemcek AA Jr, Barakat O, Benson A 3rd, Mandal R, Talamonti M, Wong CY, Miller FH, Newman SB, Shaw JM, Thurston KG, Omary RA, Salem R....

TheraSphere Metastatic Liver Disease 肿瘤负荷小，生存率好 Sato et al. Radiology 2008;247:507-515 治疗 反应好，生存率好...

TheraSphere Metastatic Liver Disease 肿瘤负荷小，生存率好 Sato et al. Radiology 2008;247:507-515 治疗 反应好，生存率好...

SIR-Spheresin 2nd-line Treatment of mCRC Investigator n Treatment ORR TTP/PFS Survival Lim30SIR-Spheres(+ 5FU/LV)70%33% 5.3 mo van Hazel 25SIR-Spheres+ irinotecan 48%6.0 mo12.2 mo 9.2 moL Limet al. BMC Cancer 2005;5:132. van Hazel et al. J...